A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation
Clinical trial NCT01807949 · COMPLETED
Trial details
- NCT number
- NCT01807949
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 563
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.